Tysabri Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Alerts
• Clinical Trials

A Study to Evaluate Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Multiple Doses of Natalizumab (BG00002) Administered Subcutaneously to Japanese Participants With Relapsing-Remitting Multiple Sclerosis
Condition:   Multiple Sclerosis, Relapsing-Remitting Intervention:   Drug: Natalizumab Sponsor:   Biogen Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 3, 2022 Category: Research Source Type: clinical trials

TOPIK Study: A Study to Report Progressive Multifocal Leukoencephalopathy and Other Serious Opportunistic Infections in Natalizumab Treated Participants
Condition:   Multiple Sclerosis Intervention:   Drug: Natalizumab Sponsors:   Biogen;   Association for Functional Rehabilitation, Recreation and Applied Kinesiology Impulse Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 11, 2022 Category: Research Source Type: clinical trials